1609 studies found for:    "Perry syndrome" OR "Parkinsonian Disorders"
Show Display Options
Rank Status Study
21 Terminated Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Subjects With Schizophrenia (Study P04628)(TERMINATED)
Conditions: Akathisia, Drug-Induced;   Dyskinesia, Drug-Induced;   Parkinsonian Disorders
Interventions: Drug: Preladenant;   Drug: Placebo
22 Enrolling by invitation Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.
Conditions: Movement Disorders;   Parkinson Disease;   Parkinsonian Disorders;   Dystonia;   Tourette Syndrome
Intervention: Procedure: Sedation with IV propofol
23 Recruiting Parkinson's Disease, Diagnostic Observations (PADDO)
Conditions: Parkinson's Disease;   Atypical Parkinsonism
Intervention:
24 Enrolling by invitation BEWARE: Body Awareness Training in the trEatment of Wearing-off Related Anxiety in Patients With paRkinson's Disease
Conditions: Parkinsonism, Experimental;   Parkinsonism, Treatment as Usual
Interventions: Behavioral: Body awareness therapy;   Other: Physical therapy
25 Terminated Brain Study of Patients With Frontal Lobe Dementia and Parkinsonian Disorders
Conditions: Alzheimer's Disease;   Dementia;   Down's Syndrome
Intervention:
26 Completed Mobilaser Study to Help With People Who Are Having Problems With Their Gait
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Device: Mobilaser
27 Enrolling by invitation DaTSCAN Imaging in Aging and Neurodegenerative Disease
Conditions: Dementia;   Parkinsonism;   Mild Cognitive Impairment;   REM Sleep Behavior Disorder
Interventions: Drug: I-123 Ioflupane solution injection prior to SPECT scan (DaTscan);   Device: Single photon emission computed tomography (SPECT) scan
28 Completed Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration;   Parkinsonism
Intervention:
29 Unknown  Botulinum Toxin for Treatment of Seborrhic Dermatitis in Parkinsonian Patients
Conditions: Parkinson Disease;   Parkinsonism;   Seborrheic Dermatitis
Intervention: Drug: Botulinum toxin
30 Completed Parkinsonism in Spinocerebellar Ataxia Type 6
Condition: Spinocerebellar Ataxia Type 6
Intervention:
31 Completed Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
Conditions: Progressive Supranuclear Palsy;   Atypical Parkinsonism
Intervention: Drug: CoenzymeQ10
32 Enrolling by invitation Targeting Monoaminergic Neuronal Networks in the Parkinsonian Patients After Carbon Monoxide Intoxication
Condition: Carbon Monoxide-induced Parkinsonism
Intervention: Radiation: 18F-FP-(+)-DTBZ
33 Completed
Has Results
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
Condition: Parkinsonian Syndromes
Intervention: Procedure: DaTSCAN SPECT imaging
34 Recruiting Parkinson's Families Project
Conditions: Parkinson's Disease;   Parkinsonism
Intervention:
35 Recruiting Identifying Biomarkers of Parkinson's Disease Using Magnetic Resonance Imaging (MRI)
Conditions: Parkinson's Disease (PD);   Parkinsonism;   Progressive Supranuclear Palsy (PSP);   Multiple System Atrophy (MSA)
Intervention:
36 Enrolling by invitation Molecular Analysis of Human Neural Stem Cells
Conditions: Parkinson's Disease;   Parkinsonism
Intervention: Procedure: Harvesting of neural stem cells
37 Completed Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
Conditions: Ataxia;   Chorea;   Dystonia;   Parkinsonism;   Fatigue
Intervention: Drug: amantadine sulphate
38 Recruiting Care for Late Stage Parkinsonism
Conditions: Parkinson's Disease;   Late Stage Parkinson's Disease
Intervention: Other: Specialist review
39 Recruiting Whole-body Vibration as a Treatment for Parkinson's Disease
Conditions: Idiopathic Parkinson's Disease;   Primary Parkinsonism
Interventions: Device: vibrating chair;   Device: sham treatment
40 Recruiting Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease
Conditions: Idiopathic Parkinson Disease;   Primary Parkinsonism
Intervention: Drug: Mesencephalic Neuronal Precursor Cells

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years